Valle, A.B.C.d.S.; Gualberto, A.C.; Ferreira, K.C.B.; Creczynski-Pasa, T.B.; Gameiro, J.; Tavares, G.D.; Pittella, F.
HOXB7 siRNA Delivered by Hybrid Nanoparticles and the Co-Therapy with Tamoxifen: Promising Strategy against Hormone Receptor-Positive Breast Cancer. Mater. Proc. 2021, 4, 69.
https://doi.org/10.3390/IOCN2020-07845
AMA Style
Valle ABCdS, Gualberto AC, Ferreira KCB, Creczynski-Pasa TB, Gameiro J, Tavares GD, Pittella F.
HOXB7 siRNA Delivered by Hybrid Nanoparticles and the Co-Therapy with Tamoxifen: Promising Strategy against Hormone Receptor-Positive Breast Cancer. Materials Proceedings. 2021; 4(1):69.
https://doi.org/10.3390/IOCN2020-07845
Chicago/Turabian Style
Valle, Ana Beatriz Caribé dos Santos, Ana Cristina Gualberto, Kézia Cristine Barbosa Ferreira, Tânia Beatriz Creczynski-Pasa, Jacy Gameiro, Guilherme Diniz Tavares, and Frederico Pittella.
2021. "HOXB7 siRNA Delivered by Hybrid Nanoparticles and the Co-Therapy with Tamoxifen: Promising Strategy against Hormone Receptor-Positive Breast Cancer" Materials Proceedings 4, no. 1: 69.
https://doi.org/10.3390/IOCN2020-07845
APA Style
Valle, A. B. C. d. S., Gualberto, A. C., Ferreira, K. C. B., Creczynski-Pasa, T. B., Gameiro, J., Tavares, G. D., & Pittella, F.
(2021). HOXB7 siRNA Delivered by Hybrid Nanoparticles and the Co-Therapy with Tamoxifen: Promising Strategy against Hormone Receptor-Positive Breast Cancer. Materials Proceedings, 4(1), 69.
https://doi.org/10.3390/IOCN2020-07845
